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Abstract 
A new heated capillary photoionization (CPI) ion source design was developed to photoionize analytes 
inside a transfer capillary between a gas chromatograph (GC) and a mass spectrometer (MS). The CPI 
setup included a wide, oval-shaped vacuum-ultraviolet (VUV) transparent magnesium fluoride (MgF2) 
window to maximize photoionization efficiency and thus sensitivity. The source contained a nitrogen 
housing around the ionization chamber inlet to avoid undesirable hydrolysis and oxidation reactions with 
ambient air and to maximize the proportion of formed molecular radical cations of analytes. The 
feasibility of the ion source was studied by analyzing 18 endogenous steroids in urine as their 
trimethylsilyl (TMS) derivatives with gas chromatography-tandem mass spectrometry (GC-MS/MS).  
The method was validated and applied to human urine samples. To our best knowledge, this is the first 
time that a capillary photoionization ion source has been applied for quantitative analysis of biological 
samples. The GC-CPI-MS/MS method showed good chromatographic resolution (peak half-widths 
between 3.1 to 5.3 s), acceptable linearity (coefficient of determination between 0.981 to 0.996), and 
repeatability (relative standard deviation (RSD%) between 5 to 18%). Limits of detection (LOD) were 
between 2 to 100 pg mL-1 and limits of quantitation (LOQ) were between 0.05 to 2 ng mL-1. In total, 15 
steroids were quantified either as a free steroid or glucuronide conjugate from the urine of volunteers. 
The new CPI source design showed excellent sensitivity for analysis of steroids in complex biological 
samples.  
Keywords 






Steroids are hydrophobic compounds synthesized from cholesterol through enzymatic reactions via 
pregnenolone to other endogenous steroids [1]. Synthesis occurs in steroidogenic tissues (such as adrenal 
glands, gonads, and placenta) and in the central nervous system [1]. Steroids have multiple biological 
functions, particularly in the cell membrane and in cell signaling, inflammation, immune functions, salt 
and water homeostasis, pregnancy, and sexual characteristics [1, 2]. Steroids can be classified based on 
the number of carbons in their molecular structure (estranes [C18], androstanes [C19], pregnanes [C21]), 
or molecular function (glucocorticoids, mineralocorticoids, progestogens, androgens, and estrogens). 
Endogenous steroid concentrations in biological samples are important in clinical diagnostics of 
disorders and treatment of endocrine diseases [3-5]. Androgenic anabolic steroids (AAS) are widely used 
as doping agents in sports and even among non-competing amateurs to increase performance. As the use 
of AAS is prohibited by the World Anti-Doping Agency (WADA) [6] and steroids have important 
biological roles and potential in drug therapeutics, analytical methods for monitoring steroid levels are 
essential.  
Urine, plasma, and serum have been primary samples in clinical and doping control analyses [4]. Urine 
is a non-invasive biofluid that is easy and painless to collect in large amounts. Steroids are excreted in 
urine (as free or in conjugated form) and thus makes it a suitable matrix for steroid analysis [5]. High 
sensitivity, accuracy, and selectivity are necessary as steroid concentrations in urine are usually low and 
variable (in the range of pg mL-1 to ng mL-1) [7], steroids have isomeric structures, and the complex 
matrix may interfere with the analysis [4]. Steroids have been classically screened using immunoassays 
(IA), but these assays have been partly replaced by mass spectrometric methods due their superior 
specificity and sensitivity [4]. Traditional mass spectrometric steroid analyses have utilized gas 
chromatography-mass spectrometry (GC-MS) [4, 8]. Liquid chromatography-mass spectrometry is also 
widely used today [3, 4]. The three most important atmospheric pressure ionization (API) techniques, 
namely electrospray ionization (ESI), atmospheric pressure chemical ionization (APCI), and atmospheric 
pressure photoionization (APPI) have all been applied in steroid analysis with LC-MS [9-11]. In ESI, the 
ionization efficiency of non-polar steroids is quite low and ESI can suffer from ion-suppression effects 
[12]. However, ionization efficiency can be improved with derivatization [13] and ESI has the advantage 
of permitting analysis of intact conjugates like glucuronides and sulfates [14, 15]. On the other hand, 




dynamic range [16], and has less matrix effects [17], although in APPI (and APCI) steroid conjugates 
are usually cleaved during the ionization process [18]. 
The popularity of GC-MS in steroid analysis relies on its resolving power (which exceeds that of LC), 
high peak capacity, and ability to separate steroid isomers [19]. GC-MS is also more robust, simple to 
use, easy to optimize, and uses a single mobile phase separation [19]. A drawback of GC-MS is the 
laborious sample pretreatment with need for chemical derivatization (usually with TMS for non-volatile 
compounds) and enzymatic hydrolysis prior to steroid analysis. Electron ionization (EI) is a commonly 
used ionization technique in GC-MS. EI typically results in extensive, characteristic fragmentation and 
the spectra can be searched against EI-MS spectral libraries. However, the fragmentation decreases 
sensitivity, selectivity, and may eliminate the formation of molecular ions, which are important for 
identification of analytes. It has been demonstrated, that the fragmentation in EI can be decreased by 
using ionization energy below the most commonly applied 70 eV, and still maintain the characteristic 
fragments needed for library matching [20, 21]. Even more effective approach to overcome the 
fragmentation is to connect the GC with MS using soft chemical ionization methods or API methods, 
such as APCI, APPI, ESI, and atmospheric pressure laser ionization (APLI) [19]. Use of e.g. triple 
quadrupole, quadrupole-time of flight, or ion trap MS enables the selective fragmentation of the 
molecular ion for reliable identification. The fragmentation of radical cations in MS/MS experiments 
follows the odd-electron fragmentation pattern and similar fragments are obtained as in EI-MS, enabling 
the usage of EI-spectral libraries [22]. When using API sources, both GC and LC can be connected to 
the same mass spectrometer equipped with an atmospheric pressure to vacuum ion optics. Expensive 
separate mass spectrometers for GC- and LC-MS analyses are therefore not needed. 
GC-APCI-MS and GC-APPI-MS have shown to be potential methods for steroid analysis [22-25]. These 
methods provide good sensitivity, a gentle ionization process, and produce intense molecular ions or 
protonated molecules with minimal fragmentation. However, in conventional APCI and APPI, analytes 
are ionized in free space between the sprayer and MS inlet, and a part of the ions are lost before entering 
the vacuum of the mass spectrometer [26]. Consequently, ion transmission and sensitivity in conventional 
APCI or APPI is not maximal. Kersten et al. were the first to introduce photoionization inside a transfer 
capillary between the atmospheric pressure and vacuum with a system having a custom miniature VUV 
lamp inside the transfer capillary [27]. While the source showed good sensitivity for volatile compounds, 




CPI method, which uses a direct interface for GC-MS and a photoionization method with high 
transmission efficiency [28]. Our CPI source is heated and VUV light enters the capillary through a 
VUV-transparent MgF2 window. Recently, Mirabelli and Zenobi used a similar heated capillary 
photoionization source and interfaced it with solid-phase microextraction sampling [29]. In this study, 
we developed a new CPI source design with a wide opening under a MgF2 window and an inert nitrogen 
atmosphere in the ionization chamber to increase sensitivity. Although the potential of capillary 
photoionization has been shown with standard solutions [27-29], thus far no studies have demonstrated 
the feasibility and validation of the method in quantitative analysis of complex biological or 
environmental samples. Here we studied the feasibility of a CPI ion source to analyze endogenous 
steroids in human urine with GC-CPI-MS/MS. A panel of 18 steroids representing various steroid 
structures and all steroid classes were chosen for the study, and their levels in free and glucuronide 
conjugate form were studied. 
2. Materials and methods 
2.1. Chemicals 
The standard compounds 17α-hydroxypregnenolone (17-OH-PREG, ≥ 97 % ), 17α-hydroxyprogesterone 
(17-OH-PROG, ≥ 95 %), 21-hydroxyprogesterone (21-OH-PROG, ≥ 97 %), aldosterone (A, ≥ 95 %), 
corticosterone (CORT, ≥ 92 %), cortisone (CS, ≥ 98 %), dehydroepiandrosterone (DHEA, ≥ 99 %), 
estrone (E1, ≥ 99 %), β-estradiol (E2, ≥ 98 %), estriol (E3, ≥ 99 %), etiocholanolone (ETIOL, ≥ 98 %), 
hydrocortisone (HC, ≥ 98 %), pregnenolone (PREG, ≥ 98 %), progesterone (PROG, ≥ 99 %), testosterone 
(T, ≥ 98 %), androsterone (ADT, 98.2 %), and 17α-methyltestosterone (Me-T, 99.5 %)  were from Sigma 
Aldrich (Steinheim, Germany). Androstenedione (AN, ≥ 97 %) was from Steraloids Inc. (Newport, RI, 
USA) and 11α-hydroxyprogesterone (11-OH-PROG, 99.1%) from Santa Cruz Biotechnology (Dallas, 
TX, USA). Standard stock solutions (1 mg mL-1 or 2 mg mL-1) of the steroids and their dilutions were 
prepared in methanol. The structures, trivial names, full names, abbreviations, steroid classes, molecular 
masses, monoisotopic masses, and molecular formulas of all analyzed steroids are presented in 
supplemental material (Table S1).  
Methanol (LC-MS chromasolv®), heptane (HPLC-grade), chlorobenzene (HPLC-grade), diethyl ether 
(chromasolv® HPLC-grade), sodium dihydrogen phosphate (≥ 99.0 %), sodium sulfate (99.0 %), β-




derivatizatization ≥ 98%), ammonium iodide (99.999 %) (NH4I), dithioerythritol (99.0 %) (DTE), 
potassium carbonate (99.7 %) (K2CO3), and sodium hydrogen carbonate (99.5-100.5 %) (NaHCO3) were 
from Sigma Aldrich. 
Artificial urine was made in-house and contained 14 g L-1 urea, 1.7 g L-1 diammonium hydrogen 
phosphate, 700 mg L-1 creatine, 700 mg L-1 glycine, 700 mg L-1 DL-α-alanine, 700 mg L-1 oxalic acid, 
350 mg L-1 bovine serum albumin (all from Sigma Aldrich), 350 mg L-1 glucose (British Drug House 
Ltd., England), and 250 mg L-1 sodium chloride (Merck, Germany) in water purified with a Milli-Q 
system (Merck Millipore, Molsheim, France). 
2.2. Samples and sample pretreatment 
Artificial urine was used as a sample matrix in method development and validation. Samples (2.5 mL) 
were spiked with 50 μL of steroid standard solution mixture (concentration levels 0.001, 0.002, 0.005, 
0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 20, 50 100, 200, 500, 1000, 2000, 5000 ng mL-11 as final 
concentration). Authentic urine samples were collected from male and female volunteers.  Urine samples 
from four males (26, 34, 38, and 49 years old) and four females (26, 31, 34, and 40 years old) were used 
to verify the suitability of the method for the analysis of steroids in an authentic matrix. Each authentic 
sample was divided into two aliquots; one aliquot was used to determine free steroids and the other 
aliquot was used to analyze the sum concentrations of steroid glucuronide conjugates and free forms. 
The concentration of glucuronide conjugate was obtained by subtracting the concentration of free steroid 
from the sum concentration.  
 
The glucuronide-conjugated steroids were hydrolyzed before extraction by adding 0.8 M sodium 
dihydrogen phosphate solution (1 mL, pH 7) and glucuronidase (50 µL) followed by incubation at 50°C 
for 1.5 hours. After enzymatic hydrolysis, steroids were extracted and derivatized similarly as the free 
steroid fraction of urine and artificial urine samples. 
 
17α-methyltestosterone was used as an internal standard with a final concentration of 10 ng mL-1. The 
sample pH (2.5 mL) was adjusted to approximately pH 8 by dissolving NaHCO3/K2CO3 (125 mg, 2:1, 
w w-1) mixture in each sample. After pH adjustment, steroids were extracted with LLE to diethyl ether; 
diethyl ether (4 mL) and Na2SO4 (1.5 g) were added to samples, followed by vortexing and centrifugation 




evaporated under nitrogen flow. The derivatization reagent mixture MSTFA/NH4I/DTE (50 µL, 
1000:2:4, v w-1w-1) was added to the test tubes, tubes were vortexed, and mixtures were transferred to 
GC vials. The samples were incubated at 60°C for 15 min to derivatize all hydroxyl and keto groups of 
steroids with TMS. After derivatization, samples were ready for injection into GC. 
2.3. Instrumentation 
2.3.1. Gas chromatography 
The analytes were separated with an HP 5892 II gas chromatograph (Hewlett-Packard, Waldbronn, 
Germany) equipped with a CTC-A200S autosampler (CTC Analytics, Zwingen, Germany). 
Chromatographic separation was obtained by combining the following two analytical columns: a TR-
5MS (15 m, i.d. 0.25 mm, film thickness 0.25 μm) and a TR-50MS (15 m, i.d. 0.25 mm, film thickness 
0.25 μm). Both columns were obtained from Thermo Scientific (Waltham, MA, USA). A methyl-
deactivated fused-silica retention gap (2 m, i.d. 0.25 mm) was installed in front of the first column and a 
deactivated fused-silica transfer capillary (1 m, i.d. 0.15 mm) after the second column; both were 
obtained from SGE Europe Ltd. (Milton Keynes, UK). All capillaries and columns were connected with 
pressfit connectors from BGB Analytik AG (Boeckten, Switzerland). The carrier gas was 99.996% pure 
helium (AGA, Espoo, Finland) with column pressure of 140 kPa. The GC temperature program started 
with a 1-min isothermal period at 190°C, after which the temperature was increased to 250°C at a rate of 
10°C min-1, from 250°C to 260°C at a rate of 1°C min-1 and from 260°C to final temperature of 330°C 
at a rate 7°C min-1.  Temperature was kept at 330°C for 3 min to clean the columns. The total runtime 
was 30 min. Samples (3 μL) were injected with 1-min splitless injection mode, and the temperature of 
the injector was 250 °C.  
 
2.3.2. Gas chromatograph-ion source interface 
Inside the GC oven, the GC transfer capillary was introduced through a stainless steel (SS) T-piece into 
a SS transfer tube (i. d. 0.5 mm). The SS transfer tube was heated (250°C) and served as a transfer line 
between the GC and MS. A few millimeters of this transfer tube and of the transfer capillary were 
introduced inside the CPI inlet capillary. A mixture of auxiliary gas nitrogen (flow rate 80 mL min-1) and 
dopant chlorobenzene (flow rate 3 µL min-1) entered the T-piece through 1/16 in o.d. SS tubing. The 
dopant was pumped into the T-piece by a Pump II Elite syringe pump from Harvard Apparatus (Holliston, 




mixture was directed into the SS transfer tubing and was transferred coaxially with the transfer capillary 
into the CPI capillary. The setup is presented in Fig. 1. 
The intersection of the transfer tube and CPI capillary was open to ambient air. MS vacuum system 
pumps approximately 1 L min-1 in to the MS, which means that in addition to GC eluent and dopant, also 
ambient air flows to the CPI ion source from the inlet. Nitrogen atmosphere was created around the CPI 
inlet capillary and the GC transfer tube interface by enclosing them in an aluminium housing, which was 
sealed and insulated with aluminium foil wrapped around the housing. Nitrogen was introduced into the 
housing through Teflon tubing with a flow rate of 4.5 L min-1. The housing was not completely gas tight 
to allow the vacuum system of the MS produce equal gas flow to that achieved without the nitrogen 
housing. However, the excess nitrogen prevented most of the ambient air from entering the ion source. 
 
2.3.3. CPI ion source 
The CPI ion source contained a SS CPI capillary (i. d. 1.5 mm) connected to a flat SS part with an oval-
shaped opening (length 17 mm, width 8 mm at the widest point, height 3 mm) which was covered with 
a 3-mm thick MgF2 window from Thorlabs Sweden AB (Gothenburg, Sweden). A SS top plate with an 
18-mm circular opening and graphite rings used as seals held the MgF2 window in place. The inlet where 
the analytes entered the ion source was heated (250°C) by a resistance wire heater driven by a DC power 
supply (ISO-TECH IPS603, RS Components, Northants, UK). The main body of the CPI device was 
heated (250°C) with a 160 W cylindrical heater (diameter 6.5 mm, length 50 mm, Oy Meyer vastus Ab, 
Askola, Finland) which was controlled by a PID500 temperature controller (Tempatron, Essex, UK). The 
heater was embedded in a cylindrical aluminium block (diameter 35 mm, height 55 mm) which was 
attached to the bottom of the CPI device. The photoionization was performed with 10.0 and 10.6 eV 
photons from an rf krypton discharge vacuum UV lamp (PKR 106, Heraeus Noblelight Analytics Ltd., 
Cambridge, UK).  
2.3.4. Mass spectrometry 
The mass spectrometer was an Agilent 6410 triple quadrupole (Agilent, Santa Clara, CA, USA). The CPI 
device was connected to the mass spectrometer glass capillary inlet. Data acquisition was performed with 
MassHunter Workstation Data Acquisition for Triple Quad software (version B.03.01) from Agilent 
Technologies. Data processing was performed with MassHunter Workstation Qualitative Analysis 
software (version B.06.00) and Quantitative Analysis software (version B.05.00) from Agilent 




scan mode with scan range m/z 150 to 750 and a scan time of 300 ms. In the MRM experiments, the 
applied dwell time for each steroid was either 100 ms or 150 ms, depending on the time segment. 
2.4. Validation 
The developed method was validated following the validation instructions of The International Council 
for Harmonisation (ICH) and identification criteria of WADA [30, 31]. LOD, LOQ, linear range, 
linearity, repeatability, LLE recovery, and carryover were studied. In total, 21 different concentration 
levels: 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 20, 50 100, 200, 500, 1000, 2000, 
5000 ng mL-1 spiked to artificial urine were tested for determination of linearity, linear range, LOD, and 
LOQ. A suitable linear range was selected based on the following criteria: maximum residual from the 
curve below 20% or below 30% in the low limit of quantitation level and quantifier/qualifier ion ratio in 
the range instructed by WADA [31]. Steroids were quantified with an internal standard method and 
identification was based on retention time and ion ratios of the selected product ions. For the calibration 
curves, 1/x weighting was applied. For ADT, ETIOL, and CS, the linear range was determined 
additionally with standard solutions (in artificial urine) which were diluted after extraction and 
derivatization. These calibration curves were applied to analyze high urine concentrations from samples 
that were also diluted after extraction and derivatization. LOD was determined based on the signal-to-
noise (S/N) ratio using criteria S/N>3 with spiked standard compounds in artificial urine. As the noise 
was nonexistent for some of the compounds, a three-fold signal compared to reagent blank was also 
required. The LOQ criteria was S/N>10, maximum deviation from the calibration curve 30%, and 
quantifier/qualifier ratio in the range accepted by WADA [31]. Repeatability and LLE recovery were 
determined at a concentration level of 10 ng mL-1 from six replicates. Recovery was determined by 
comparing the responses of spiked extracted samples to standard solution spiked at the same 
concentration level. Carryover was studied by analyzing a blank sample (extracted artificial urine) after 
analysis of extracted 200 ng mL-1 standard solution (in artificial urine) and by calculating the relative 
ratio of peak area of blank compared to the peak area of the standard solution.  
3. Results and discussion 
3.1. CPI ion source development  
A new CPI source with a wide, low-depth ionization chamber under the wide MgF2 window was designed 




diameter of the window of the applied VUV lamp is 13 mm, the wide surface area of the opening provides 
high photon flux into the source, ensuring high ionization efficiency and thus sensitivity. The low depth 
and oval shape of the ion chamber were designed to minimize dead volume and dead angles. In fact, the 
volume of the ionization chamber (<0.4 mL) is negligible compared to the total gas flow rate through the 
chamber (approximately 1 L min-1). The ionization chamber was heated with a 160-W cylindrical heater 
embedded in a cylindrical aluminium block. PID temperature control of the heater and thermal mass of 
the aluminium block ensured stable and sufficiently high temperature to avoid adsorptions of the 
analytes. Together, these features ensured that the design of the ionization chamber did not cause peak 
tailing, broadening, or carryover as also shown experimentally (Table 1 and Fig. S1 in supplementary 
data).   
 
In this design, a nitrogen housing was built around the CPI source inlet to provide an inert gas 
environment to the CPI source. Because ionization and the used MS require larger gas flow 
(approximately 1 L min-1) than provided by the GC and the dopant vaporization system, without the 
housing ambient air would flow into the CPI source and atmospheric changes could affect the 
photoionization process. When nitrogen housing was utilized, abundant analyte radical cations ([M]•+) 
were formed and formation of other ions was minimal. Without the housing, the intensities of other ions, 
such as [M+H]+, [M-TMS]•+, [M-TMSOH]•+, and [M+O2]
•+ were increased as  presented and discussed 
in the supplementary material.  
3.2. GC-MS/MS method development 
The MS spectra of the TMS-derivatized steroids were measured to select the precursor ions for MS/MS 
analysis. The most intensive ion for all the steroids except for CS and HC was [M]•+, which was selected 
as the precursor ion. The protonated molecule [M+H]+ was not observed for any of the TMS-derivatized 
steroids taking into account the isotopic distribution of the [M]•+ ion (Fig. S2, Fig. S3 in supplementary 
data). The low ionization energy of TMS-derivatized steroids favors a charge-exchange reaction and 
formation of [M]•+. On the other hand, the relatively low proton affinity of the TMS-derivatized steroids 
does not favor a proton-transfer reaction. These results are consistent with previous studies [22, 28]. For 
CS- and HC-TMS, the most intense ion was [M-TMSOH]•+, which was selected as a precursor ion for 
these compounds. For almost all steroids, the [M-TMS]•+ ion was also seen as a minor peak in the MS 




non-specific fragments corresponding to the loss of CH3 [M-15]
•+, TMSOH [M-90]•+, CH3 + TMSOH 
[M-105]•+, CH3 + 2xTMSOH [M-195]
•+, and [TMS]•+ peak with m/z 73 (Fig. S2 and Fig. S3 in 
supplementary data). Specific fragments from the ring structure were also observed for all steroids. For 
the MRM method, two of the most intense sufficiently specific fragment ions were selected and collision 
energies for the transitions were optimized (Table S2 in supplementary data). However, for ADT, 
ETIOL, and internal standard, less abundant ions were selected for MRM. For ADT and ETIOL, 
selectivity was a more crucial parameter than sensitivity, since concentrations of these steroids are high 
in urine [7]. 
 
Two GC columns (TR-5MS and TR-50MS, see chapter 2.3.1.) connected in tandem were used to improve 
the separation of isobaric steroids and isotopes of co-eluting compounds as described in our previous 
study [22]. All steroids could be unambiguously detected and identified based on chromatographic 
separation and selective MRM transitions. Retention times of the steroids varied between 13.38 and 26.05 
min (Table 1 and Table S2 in supplementary data); separation is shown in Fig. 2. Chromatographic 
separation with the method was good, and retention time RSDs below 1%. Peaks were symmetric and 
narrow with peak half widths in the range of 3.1 to 5.3 s (Table 1.). This indicates that the dead volume 
of the ion source was sufficiently small. Also, the ion source and transfer line materials and temperatures 
were adequate to avoid any cold traps, which could cause peak tailing and broadening. All the applied 
MRM transitions, MS parameters, and measured retention times are presented in Table S2 in 
supplementary data.  
3.3. Method validation  
The method was validated in terms of recovery of LLE, LOD, LOQ, linearity, repeatability, and carryover 
(Table 1). The separate MRM chromatograms for steroids in standard solution (5 ng mL-1), in the free 
steroid fraction of urine (male 38 years), in the glucuronide fraction of urine (male 38 years), and in a 
blank sample (extracted artificial urine) are shown in Fig. S1 in supplementary data. LODs were in the 
equal range of 0.002 to 0.02 ng mL-1 for most of the steroids, with exception of A, ADT, ETIOL, and 
HC with slightly higher LODs (0.05-0.1 ng mL-1). The higher LODs for ADT and ETIOL can be 
explained by the selection of less abundant but more selective ions for quantitation. LODs reported in 
the literature for GC-EI-MS analysis of steroids from urine have ranged from 0.5 to 20 ng mL-1 for AAS 




37],  0.001 to 0.4 ng mL-1 for estrogens [35, 38], and 0.3 to 2 ng mL-1 for progestogens [35]. GC-EI-
MS/MS LODs for AAS have ranged from 0.02 to 100 ng mL-1 [39]. With LC-MS the LODs have ranged 
0.1 to 10 ng mL-1 for AAS [11] and 0.02 to 113 ng mL-1 for corticosteroids [36, 37], and LOQs for 
estrogens ranged from 0.02 to 0.05 ng mL-1[38, 40]. LODs and LOQs of our GC-CPI-MS method were 
mainly lower than values reported previously in the literature [32-40], thus showing high sensitivity of 
the method. For estrogens our LODs and LOQs were slightly higher or in the same range as with GC-
EI-MS reported previously [35, 38]. Considering that the measurements were performed with an over 
10-year-old mass spectrometer, even higher sensitivity could be achieved if a modern mass spectrometer 
was used.  
 
Repeatability of all steroids was reasonable with RSD values varying between 5 to 18% for six replicates 
at the level 10 ng mL-1. These RSD values were on the same range as reported previously for GC-EI-MS 
systems.[33-35] Linearity was acceptable with a coefficient of determination (R2) varying between 0.981 
to 0.996. The linear range covered 2 to 4 orders of magnitude in the range 0.05 to 200 ng mL-1. Linear 
range coverage, linearity, and R2 values showed similar analytical performance as obtained with GC-EI-
MS systems [33-36]. LLE recoveries were in the range of 57.3 to 123.7%. Carryover was below 0.01% 
for all analytes, and only E2 showed some residual response in the blank sample above LOD but below 
LOQ. 
3.4. Application to human urine samples  
The method was applied to analyze the urine of eight volunteers (4 females 26-40 years old and 4 males 
26-49 years old) (Table 2 and Fig. S1 in supplementary data).  Although sampling, normalization, 
circadian rhythm, menstrual cycle phase, and biological variation between individuals, and detection of 
different conjugates largely affect the measured urine concentrations of steroids, our data is in agreement 
with literature. As expected, concentrations of most of the steroid glucuronide conjugates were higher or 
at the same level compared to the respective free steroids, and only 11-OH-PROG and 17-OH-PROG 
showed levels below LOQ in all samples also as glucuronide conjugates (Table 2). The glucuronides of 
ADT and ETIOL are the main endogenous metabolites of testosterone and were excreted in urine at high 
concentrations (100-2000 ng mL-1) as also reported previously (median ADT 2260 ng mL-1  and ETIOL 
1850 ng mL-1 in males, ADT 1470 ng mL-1 and ETIOL 1480 ng mL-1 in females)[7]. The detected 




the literature in a study of over 3000 subjects was approximately 35 ng mL-1[7]. The corticosteroids CS 
and HC had the highest observed free-form concentrations (10-100 ng mL-1), being at the same level as 
their glucuronide conjugates. The average corticosteroid concentrations previously reported in the free 
form and glucuronide conjugate after hydrolysis with β-glucuronidase were 23.2 ng mL-1 and 22.3 ng 
mL-1 for hydrocortisone and 42 ng mL-1 and 46 ng mL-1 for cortisone, respectively [41]. The data showed 
clear differences in male and female samples regarding sex steroids; testosterone was higher in males 
(mean 16.9 ng mL-1 in males, 1.8 ng mL-1 in females) and estrogens were higher in females (>2 fold 
difference in the mean values), as also reported in the literature [7, 35, 40]. The detected mean estrogen 
glucuronide concentrations for females were 4.3 ng mL-1 for E1, 1.4 ng mL-1 for E2, and 3.9 ng mL-1 for 
E3; these are consistent with the estrogen concentrations detected previously from premenopausal 
women (median 7 ng mL-1 for E1, 2.5 ng mL-1 for E2, and 7.8 ng mL-1 for E3) [38]. Additionally, small 
concentrations of AN and CORT were detected in the free form and 17-OH-PREG, 21-OH-PREG, A, 
AN, CORT, and PREG as glucuronide conjugates.  
Our results also agree with results obtained with open GC-APPI-MS-interface previously used in our 
laboratory with the same mass spectrometer [22]. However, the LODs were approximately one order of 
magnitude lower with the CPI as with the previous open APPI interface. With CPI we detected the free 
forms of DHEA and CORT (Fig. 3) and the glucuronides of 17-OH-PREG, CORT (Fig. 3), and A, which 
were not detected with the open APPI interface. These results show that CPI provides very high 
sensitivity and good quantitative performance for the analysis of steroids in urine samples.  
4. Conclusions 
A new capillary photoionization (CPI) source design was developed and its quantitative performance 
evaluated in the analysis of selected steroids in urine. This is the first time that a CPI-type ion source has 
been applied in the quantitative analysis of a large analyte group from a real biological matrix. The 
developed GC-CPI-MS/MS method showed high chromatographic resolution, high sensitivity, 
specificity, and analytical performance to quantify steroids from human urine samples. Sensitivity of the 
system for analysis of steroids was better compared to GC-EI-system and it may be still improved with 
analyte specific optimization. This study shows that CPI source has a potential for analysis of non-polar 
compounds with high sensitivity from complex biological matrices and encourages to utilize CPI in more 
advanced GC applications, which might be challenging by EI-MS. We showed that the CPI ion source 




proton-transfer as well as fragmentation is minimal. This, and the possibility to combine GC with 
hyphenated high resolution API mass spectrometers via CPI introduces a possibility to use GC for non-
targeted analysis to discover elemental compositions of unknowns. As there is some evidence in literature 
that the fragmentation of radical cations follows the same odd-electron fragmentation pathways as in EI, 
it might still be possible to use EI-spectral libraries for identification of MS/MS spectra. Furthermore, 
GC-EI-MS is limited to low carrier gas flow rates (1-2 mL min-1) due to the vacuum of ionization 
chamber. With CPI interface, carrier gas flow rates are not limited, which is expected to enable fast GC 
with wide or mega pore columns and large injection volumes.   
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Fig. 1. 3D-schematic of the GC-CPI ion source setup (available also as 3D-PDF). Parts marked in the 
figure; 1.GC oven, 2. GC transfer capillary, 3.  SS T-piece, 4. SS transfer tube, 5. Heated transfer line, 6. 
Heated CPI inlet capillary, 7. Dopant and nitrogen gas line, 8. Nitrogen atmosphere in an aluminium 
housing, 9.Nitrogen flow through Teflon tubing, 10. Oval-shaped opening under MgF2 window, 11. 
Heated aluminium block, 12. Temperature control of cylindrical heater 13. CPI capillary, 14. Inlet into 
mass spectrometer. Parts 5. and 8. were insulated with aluminium foil. 
 
Fig. 2. Overlaid MRM chromatograms of quantifier ions of the studied steroids analyzed from 10 ng 






Fig. 3. DHEA, CORT, E1, and 17-OH-PREG MRM chromatograms (quantifier as black and qualifier 
as red) in a male (38y) urine sample from free steroid and glucuronide fractions, standard compound (5 







Table 1. Chromatographic peak parameters and validation results for steroids; chromatographic peak 
full width at half maximum (FWHM), symmetry factor, linear range, R2 of calibration curve, LOD, 









LOD    
(ng mL-1) 
LOQ   
(ng mL-1) 






11-OH-PROG 23.61 0.07 3.12 1.04 0.02 0.2 0.2-50 0.991 11.6 82.1 
17-OH-PREG 20.93 0.07 4.50 1.01 0.01 0.1 0.1-100 0.988 12.9 122.1 
17-OH-PROG 22.38 0.07 3.96 0.96 0.01 0.5 0.5-100 0.990 10.2 123.7 
21-OH-PROG 24.77 0.05 3.84 1.12 0.002 0.2 0.2-100 0.995 5.0 62.9 
A 26.02 0.04 5.28 1.25 0.1 2 2-200 0.992 12.6 70.3 
ADT 13.38 0.20 4.62 1.18 0.1 2 2-100 0.988 8.5 70.2 
ADT*       100-2000 0.994   
AN 16.92 0.14 5.10 0.91 0.02 0.5 0.5-50 0.992 7.5 79.4 
CORT 25.56 0.04 3.42 0.92 0.01 0.2 0.2-20 0.993 11.1 83.4 
CS 24.82 0.05 3.78 1.02 0.01 0.5 0.5-100 0.995 17.6 75.4 
CS*       100-1000 0.997   
DHEA 15.05 0.13 3.78 1.00 0.01 0.05 0.05-100 0.996 5.3 75.7 
E1 17.85 0.11 4.80 1.13 0.01 0.1 0.1-100 0.994 10.3 72.6 
E2 17.98 0.11 4.74 0.93 0.01 0.1 0.1-100 0.995 10.3 73.6 
E3 21.04 0.07 4.26 1.13 0.005 0.1 0.1-100 0.989 5.7 81.0 
ETIOL 13.56 0.23 4.50 0.97 0.05 0.1 0.1-100 0.996 9.0 75.4 
ETIOL*       100-2000 0.997   
HC 25.82 0.04 3.60 0.90 0.05 1 1-100 0.981 18.0 57.3 
PREG 20.29 0.07 4.26 0.96 0.01 0.5 0.5-20 0.990 13.6 64.0 
PROG 21.85 0.09 4.32 0.93 0.02 0.1 0.1-100 0.995 5.5 64.3 






Table 2. Concentrations of analyzed steroids in urine of 8 volunteers either in the free or in the 
glucuronide-conjugated form. Concentrations of glucuronide conjugates were obtained by subtracting 
free steroid concentration from the concentration of total steroid after enzymatic hydrolysis.  All values 













A ADT AN CORT CS DHEA E1 E2 E3 ETIOL HC PREG PROG T 
Free fraction 
  
                                  
Male 26 y - - <LOQ - - - 0.9 - 18 0.3 <LOQ - - <LOQ 2.7 <LOQ - <LOQ 
Male 34 y - <LOQ <LOQ - - - 1.3 0.2 47 1.7 <LOQ - <LOQ 1.9 37 <LOQ - <LOQ 
Male 38 y - <LOQ <LOQ - - - 1.1 0.3 66 0.4 <LOQ - <LOQ 4.9 38 <LOQ - <LOQ 
Male 49 y - <LOQ <LOQ - - - 0.9 0.3 87 0.2 <LOQ - - 0.8 43 <LOQ <LOQ <LOQ 
Female 26 y - <LOQ <LOQ - - - 0.7 <LOQ 41 0.7 <LOQ - <LOQ 1.3 22 <LOQ - <LOQ 
Female31 y - <LOQ <LOQ - - - <LOQ - 30 0.2 <LOQ - <LOQ 0.1 5.2 <LOQ - - 
Female 34 y - <LOQ <LOQ - - - 0.6 0.2 58 0.2 <LOQ - <LOQ 0.8 16 <LOQ 0.1 <LOQ 
Female 40 y - - <LOQ - - - 0.7 - 56 0.7 <LOQ - <LOQ 1.1 12 <LOQ - - 
                 
  
Glucuronide fraction 
               
  
Male 26 y - 0.3 <LOQ <LOQ <LOQ 270b 0.2 <LOQ 7.8 11 0.7 0.2 0.8 150b 3.0 0.6 - 6.5 
Male 34 y <LOQ 1.2 <LOQ 0.2 2.8 1000b 0.5 1.1 48 34 1.7 0.8 3.2 1000b 26 1.4a - 23 
Male 38 y -* 0.8 <LOQ 0.3 2.4 1400b 0.7 1.6 81 23 1.9 0.6 1.6 1900b 31 1.1a - 28 
Male 49 y <LOQ 0.8 <LOQ 0.2 4.2 720b 0.3 1.7 90b 21 1.1 0.3 1.3 570b 33 0.7 - 10 
Female 26 y - 0.7 <LOQ <LOQ <LOQ 380b 0.2 1.1 27b 17 1.4 0.3 0.9 1200b 13 0.8a - 1.3 
Female 31 y - 0.6 <LOQ <LOQ <LOQ 600b 0.6 0.2 10 13 4.2 1.4 3.6 610b 4.2 0.9a - 1.9 
Female 34 y <LOQ 0.2 <LOQ <LOQ 2.1 470b 0.2 1.0 42 21 3.0 0.9 3.5 1100b 19 0.6a 0.1 <LOQ 
Female 40 y <LOQ 0.7 <LOQ <LOQ 3.6 1100b 0.5 0.9 28 37 8.6 3.2 7.6 560b 26 <LOQ <LOQ 2.3 
*=interfering background noise above LOQ   
a=interfering background in qualifier, quantifier/qualifier ratio above allowed limit 
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Table S2. Steroid MRM transitions and optimized mass spectrometer parameters.  





















ion CE (V) 
ADT 1 13.38 M•+ 2 TMS 434.3 180 161.2 20 195.2 20 
ETIOL 
 
13.56 M•+ 2 TMS 434.3 170 155.1 25 221.1 40 
DHEA 2 15.05 M•+ 2 TMS 432.3 170 327.3 20 169.1 25 
AN 3 16.92 M•+ 2 TMS 430.2 190 209.1 30 234.1 30 
T 
 
16.99 M•+ 2 TMS 432.2 180 209.1 30 301.2 35 
E1 4 17.85 M•+ 2 TMS 414.2 180 155.1 25 309.2 25 
E2 
 
17.98 M•+ 2 TMS 416.2 180 285.2 25 129.1 25 
Me-T (ISTD) 5 19.04 M•+ 2 TMS 446.3 180 301.2 30 314.3 25 
PREG 
 
20.29 M•+ 2 TMS 460.3 160 157.1 30 265.2 30 
17-OH-PREG 6 20.93 M•+ 3 TMS 548.3 180 231.1 30 230.1 35 
E3 
 
21.04 M•+ 3 TMS 504.3 180 311.2 20 324.2 20 
PROG 7 21.85 M•+ 2 TMS 458.3 170 157.1 30 353.2 30 
17-OH-PROG 
 
22.38 M•+ 3 TMS 546.3 170 301.2 35 314.2 30 
11-OH-PROG 8 23.61 M•+ 3 TMS 546.3 170 351.3 30 233 35 
21-OH-PROG 9 24.77 M•+ 3 TMS 546.3 170 301.2 35 230.1 30 
CS 
 
24.82 [M-TMSOH]•+  5 TMS 630.3 190 243.1 40 283.1 40 
CORT 10 25.56 M•+ 4 TMS 634.4 170 230.1 35 404.3 25 
HC 
 
25.82 [M-TMSOH]+.  5 TMS 632.2 180 234.1 40 437.2 40 














Figure S1. Extracted ion chromatograms of steroids from a male (38y) urine sample from free steroid 
and glucuronide fractions, standard compound (5 ng mL-1) spiked in artificial urine and blank sample 
(note that different intensity scales are used for clear visualization). Quantifier transition and 





Figure S1. Extracted ion chromatograms of steroids from a male (38y) urine sample from free steroid 
and glucuronide fractions, standard compound (5 ng mL-1) spiked in artificial urine and blank sample 
(note that different intensity scales are used for clear visualization). Quantifier transition and 





Figure S1. Extracted ion chromatograms of steroids from a male (38y) urine sample from free steroid 
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Detailed methods and results on the development of nitrogen housing 
As gas flow towards MS was higher than the gas flow provided by GC and dopant system, ambient air 
could flow into the CPI, possibly affecting to photoionization process, which was mainly prevented by 
building up a nitrogen atmosphere around the ion chamber. The effect of the nitrogen atmosphere was 
studied by measuring the spectra of the TMS derivatives of steroids with and without the nitrogen 
housing. Results for E2, ADT, and DHEA are shown as examples in Fig. S2 and Fig. S3. An abundant 
radical cation ([M]•+) was formed with nitrogen housing and formation of other ions was minimal. 
Without the housing, the intensities of [M+H]+, [M-TMS]•+, [M-TMSOH]•+, and [M+O2]
•+ were 
increased, possibly due to reactions with molecules of ambient air such as oxygen and water. The 
formation of [M+H]+ is most likely due to atmospheric water, which, in photoionization, produces 
protonated water cluster reagent ions that favor proton transfer reactions [32]. [M-TMS]•+ was not 
observed in the product ion spectra of the steroids (Fig. S2, Fig. S3 in supplementary data) and thus it is 
unlikely that it is formed by in-source fragmentation of the radical cation. The reason for observing [M-
TMS]•+ may be that atmospheric water promotes gas-phase hydrolysis of the TMS derivatives, and the 
hydrolysis product [M-TMS] is then ionized by a charge exchange reaction in the CPI source. The 
reaction may also be photocatalyzed, and the OTMS group can be substituted with photon-generated 
hydroxyl radical prior to ionization. To demonstrate the effect of the changing atmospheric 
environment to the photoionization process, spectra were also measured on two separate days in a 
laboratory kept at approximately 21°C without a dehumidifier and with a two-fold difference in 
absolute humidity between the measurement days (Fig. S3). Without nitrogen housing, the humidity 
clearly correlated with the formation of [M+H]+ and [M-TMS]•+ ions (Fig. S3) although other 
fluctuations in the laboratory air contents may also contribute to the obtained result. With nitrogen 
housing, the spectra showed no significant changes related to ambient conditions or absolute humidity. 
This demonstrates that in GC-APPI-MS analysis, the variations in ambient air composition may have a 
significant effect on the photoionization process and these variations can be eliminated by using 






Figure S2. Backgroud-substracted mass spectra of ADT (A,B) and DHEA (D,E) measured from the 
same samples on the same day with (B,E) and without (A,D) nitrogen housing. Product ion spectra of 
ADT (collision energy 20V) and DHEA (collision energy 25V) radical cations (C and F). 
 
 
Fig. S3. Background-subtracted MS-scan spectra of E2 with nitrogen housing (A and B) and without 
nitrogen housing (C and D). The absolute humidity of the measurement days were 6 g m-3* (B, D); 12 
g m-3* (C); and 11 g m-3* (A). Figure 2E shows the product ion spectrum of E2 radical cation ([M]•+ at 
m/z 416) with collision energy 20V and scan range 50-500. *Absolute humidity was calculated based 
on the average observations (temperature, pressure, relative humidity) on the measurement day 












Figure S4. Mass spectra of TMS-derivatized steroid standard compounds. Peaks from co-eluting 
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Figure S4. Mass spectra of TMS-derivatized steroid standard compounds. Peaks from co-eluting 
compounds marked with *. 
 
